Amgen

IFBC was mandated by Amgen to value a minority stake in an Italian biotechnology company. The project included the development of a business plan, the valuation based on the DCF-approach, multiple valuations as well as an @risk valuation. Amgen is one of the leading independent biotechnology company worldwide.